Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Prevention/Epidemiology

Chiron, Roche Reach Settlement Agreement on Dispute Over Patent on HIV Testing Methods

September 14, 2004

Emeryville, Calif.-based biotechnology company Chiron has announced that it has reached a settlement with Swiss-based pharmaceutical company Roche over licensing fees and royalties for a patent on HIV testing methods, AFX News reports (AFX News, 9/12). The dispute was based on Chiron's claims that it was owed licensing fees and royalties from Roche under a licensing agreement related to its March 2003 patent for nucleic acid HIV testing methods, according to the Wall Street Journal (Wall Street Journal, 9/13). Under the agreement, Chiron will receive a lump sum of $78 million in place of royalties after Jan. 1, 2005, and will retain all of the money paid by Roche while the matter was under dispute. Under the agreement, Roche also must agree to the "validity and enforceability" of Chiron's patent, according to AFX News. However, Roche has the option to obtain a partial refund and choose to pay royalties on the sales of the testing products in North America (AFX News, 9/12).

Back to other news for September 14, 2004


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement